Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for GLP-1 Receptor Agonist Exposure and Survival Outcomes in Newly Diagnosed Multiple Myeloma Treated With Daratumumab-Based Quadruplet Therapy: A Target Trial Emulation

MM - 626

GLP-1 Receptor Agonist Exposure and Survival Outcomes in Newly Diagnosed Multiple Myeloma Treated With Daratumumab-Based Quadruplet Therapy: A Target Trial Emulation

Colton Jones

Poster Presenter: Colton Jones

Thumbnail for Treatment of high-risk smoldering multiple myeloma (HRSMM) with Isatuximab, lenalidomide, oral Cyclophosphamide and Dexamethasone: a survival advantage

MM - 633

Treatment of high-risk smoldering multiple myeloma (HRSMM) with Isatuximab, lenalidomide, oral Cyclophosphamide and Dexamethasone: a survival advantage

Maher Salamoon

Poster Presenter: Maher Salamoon

Previous 1...117 118 119 120 121 122 123...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Primary Prophylaxis With Immunoglobulin Replacement Therapy Is Associated With Lower Cumulative Infection Burden and Healthcare Utilization in Patients With Multiple Myeloma Receiving BCMA-Directed BsAbs

MM - 647

Primary Prophylaxis With Immunoglobulin Replacement Therapy Is Associated With Lower Cumulative Infection Burden and Healthcare Utilization in Patients With Multiple Myeloma Receiving BCMA-Directed BsAbs

Patricia Lugar

Poster Presenter: Patricia Lugar

Thumbnail for Acid Suppression and Plasma Cell Persistence: Does PPI Use Compromise the Efficacy of First-Line Daratumumab-Based Quadruplets?

MM - 651

Acid Suppression and Plasma Cell Persistence: Does PPI Use Compromise the Efficacy of First-Line Daratumumab-Based Quadruplets?

Travis Stueber

Poster Presenter: Travis Stueber

Thumbnail for Safety and Efficacy of Subcutaneous Daratumumab Plus VRd in Frontline Treatment of Newly Diagnosed Multiple Myeloma: A Preliminary Real-World Indian Experience

MM - 670

Safety and Efficacy of Subcutaneous Daratumumab Plus VRd in Frontline Treatment of Newly Diagnosed Multiple Myeloma: A Preliminary Real-World Indian Experience

Ajay Gogia

Poster Presenter: Ajay Gogia

$Thumbnail for Efficacy and Safety of Teclistamab in Extramedullary Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis$

MM - 673

Efficacy and Safety of Teclistamab in Extramedullary Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Shivam Rainchwar

Poster Presenter: Shivam Rainchwar

Thumbnail for Prognostic Value of Baseline EASIX in Multiple Myeloma: A Single-Center Retrospective Study

MM - 675

Prognostic Value of Baseline EASIX in Multiple Myeloma: A Single-Center Retrospective Study

Kareem Latif

Poster Presenter: Kareem Latif

$Thumbnail for Outpatient Administration of Ciltacabtagene Autoleucel (CARVYKTI) in Relapsed/Refractory Multiple Myeloma: A Single-Center Feasibility, Safety, and Efficacy Analysis$

MM - 679

Outpatient Administration of Ciltacabtagene Autoleucel (CARVYKTI) in Relapsed/Refractory Multiple Myeloma: A Single-Center Feasibility, Safety, and Efficacy Analysis

Dipen Khanapara

Poster Presenter: Dipen Khanapara

Thumbnail for Septicemia as a Concurrent Condition in Multiple Myeloma Mortality: Trends and Racial/Ethnic Disparities in the United States, 2018-2024: A CDC WONDER Database Analysis

MM - 682

Septicemia as a Concurrent Condition in Multiple Myeloma Mortality: Trends and Racial/Ethnic Disparities in the United States, 2018-2024: A CDC WONDER Database Analysis

Krutika Gohil

Poster Presenter: Krutika Gohil

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors